Charles Schwab
PRNB

Charles Schwab’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Charles Schwab’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-147,863
Closed -$8.84M – 3376
2020
Q2 		$8.84M Buy
147,863
+31,143
+27% +$1.92M ﹤0.01% 1721
2020
Q1 		$6.93M Buy
116,720
+1,652
+1% +$96.3K ﹤0.01% 1660
2019
Q4 		$6.3M Buy
115,068
+47,333
+70% +$1.77M ﹤0.01% 1902
2019
Q3 		$1.91M Buy
67,735
+5,968
+10% +$219K ﹤0.01% 2392
2019
Q2 		$2.05M Buy
61,767
+17,237
+39% +$538K ﹤0.01% 2363
2019
Q1 		$1.51M Buy
44,530
+1,051
+2% +$33.4K ﹤0.01% 2441
2018
Q4 		$1.19M Buy
+43,479
New +$1.12M ﹤0.01% 2488

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Charles Schwab's PRNB Position: Q3 2020 in Review

Charles Schwab sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 147,863 shares — an estimated $8.84M sold.

Charles Schwab first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $8.84M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Charles Schwab reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Charles Schwab sold 147,863 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $8.84M.
  • Charles Schwab first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • Charles Schwab's Principia Biopharma Inc. Common Stock position peaked at $8.84M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Charles Schwab's 13F filing for Q3 2020, filed 13 Nov 2020.